Session(s)
- A Global Evaluation of Agreement on the Decision to Perform Surgical Lung Biopsy Between P...
Sunday, May 20 9:15 AM - 11:15 AM - Identifying Opportunities for Earlier IPF Diagnosis [Board No. 103]
Sunday, May 20 9:15 AM - 11:15 AM - Severity of Sleep Disordered Breathing in Patients with Idiopathic Pulmonary Fibrosis and ...
Sunday, May 20 9:15 AM - 11:15 AM - Indication for and Impact of Switching from Pirfenidone to Nintedanib in Idiopathic Pulmon...
Sunday, May 20 11:15 AM - 1:00 PM - Investigating the Effect of Nintedanib on Changes in Biomarkers of ECM Turnover in Patient...
Sunday, May 20 11:15 AM - 1:00 PM - Longitudinal Health Related Quality of Life in Patients with Idiopathic Pulmonary Fibrosis...
Sunday, May 20 11:15 AM - 1:00 PM - Multidisciplinary Team Meeting Agreement on Diagnosis in Idiopathic Interstitial Pneumonia...
Sunday, May 20 11:15 AM - 1:00 PM - Pirfenidone in Patients with Unclassifiable Progressive Fibrosing Interstitial Lung Diseas...
Sunday, May 20 11:15 AM - 1:00 PM - Measuring Cough and Its Impact on Quality of Life in Fibrotic Lung Disease [Board No. 214]
Sunday, May 20 2:15 PM - 4:15 PM - Preliminary Testing of the Idiopathic Pulmonary Fibrosis Patient Reported Outcome Measure ...
Sunday, May 20 2:15 PM - 4:15 PM - A Randomized, Placebo-Controlled, Double Blind Phase Iia Clinical Trial to Assess the Safe...
Sunday, May 20 2:45 PM - 3:00 PM - Experiences of Supplemental Ambulatory Oxygen for Patients with Fibrotic Lung Disease: Qua...
Sunday, May 20 3:15 PM - 3:30 PM - Improvement in Gait Speed with Pulmonary Rehabilitation Is Associated with Increased Survi...
Sunday, May 20 3:45 PM - 4:00 PM - Five-Repetition Sit-to-Stand Test in Idiopathic Pulmonary Fibrosis
Sunday, May 20 4:00 PM - 4:15 PM - Changes in Biomarkers of Collagen Synthesis and Degradation Correlate with Disease Progres...
Monday, May 21 9:15 AM - 11:15 AM - Pulmonary 18F-FDG Up-Take Refines Current Risk Stratification in Non Specific Interstitial...
Monday, May 21 11:15 AM - 1:00 PM - Physical Frailty in Idiopathic Pulmonary Fibrosis [Board No. 412]
Monday, May 21 2:15 PM - 4:15 PM - PI3kinase/mTOR Inhibition Alters Global Metabolism in IPF Patients: Exploratory Biomarker ...
Tuesday, May 22 9:15 AM - 11:15 AM - Longitudinal Prediction of Outcome in Idiopathic Pulmonary Fibrosis Using Automated CT Ana...
Tuesday, May 22 3:15 PM - 3:30 PM - The RIFF Study (Cohort A): A Phase II, Randomized, Double-Blind, Placebo-Controlled Trial ...
Wednesday, May 23 10:30 AM - 10:45 AM - The RIFF Study (Cohort B): A Phase II, Randomized, Double-Blind, Placebo-Controlled Trial ...
Wednesday, May 23 10:45 AM - 11:00 AM - No Relevant Pharmacokinetic Interaction Between Nintedanib and Pirfenidone in Patients wit...
Wednesday, May 23 1:30 PM - 3:30 PM